Connect with us

Video

Why Pfizer Is Betting Big On An Unproven Treatment For Covid-19 | Forbes

Published

on

On the first Monday of May, Pfizer dosed the initial batch of healthy American volunteers in Baltimore with an experimental Covid-19 vaccine it developed with Germany’s Bio-NTech. Bourla was informed immediately. The following day, in an interview from his home in suburban Scarsdale, New York, he pointed out that it normally takes years to accomplish what Pfizer had just done in weeks. “How fast we moved is not something you could expect from the big, powerful pharma,” he said. “This is speed that you would envy in an entrepreneurial founder-based biotech.”

A Greek veterinarian who worked his way up the Pfizer corporate ladder for 25 years before becoming CEO in 2019, Bourla says nothing in his career could have prepared him for this moment. But he does believe the massive corporate transformation he has led—steering a behemoth conglomerate (2019 sales: $51.8 billion) deeper into the high-risk, high-reward game of developing new patented medicines and away from generic drugs and consumer products like Advil and Chapstick—has prepared Pfizer.

For Bourla, 58, the last four months have been a rollercoaster, an unending series of setbacks and victories. Pfizer is not alone in the race. Most of the world’s biggest pharmaceutical companies, including Johnson & Johnson, Sanofi, AstraZeneca and Roche, are throwing everything they can at Covid-19.

Some experts feel Bourla’s timeline—a viable vaccine in a matter of a few months—is simply unrealistic. Undeterred, Bourla has tasked hundreds of researchers to scour Pfizer’s trove of experimental and existing medicines to look for potential therapies. Early on, he openly authorized having discussions and sharing proprietary information with rival firms, moves unheard of in the secretive world of big pharma. Bourla has made Pfizer’s manufacturing capabilities available to small biotech concerns and is in talks as well to make large quantities of other companies’ Covid-19 drug candidates.

Pfizer’s most prominent effort is its work with Mainz, Germany–based BioNTech, an innovative $120 million (2019 sales) outfit that is mostly known for making cancer medications. The resulting experimental Covid-19 vaccine works with messenger RNA, a bleeding-edge technology that has never resulted in a successful treatment. Pfizer is hoping to get emergency-use authorization from the U.S. government for the vaccine by October. Its unique strategy is to rapidly pit four different mRNA vaccine candidates against one another and double down on the most likely winner.

Read the full profile on Forbes: https://www.forbes.com/sites/nathanvardi/2020/05/20/the-man-betting-1-billion-that-pfizer-can-deliver-a-vaccine-by-this-fall/#69185f30382e

Subscribe to FORBES: https://www.youtube.com/user/Forbes?sub_confirmation=1

Stay Connected
Forbes newsletters: https://newsletters.editorial.forbes.com
Forbes on Facebook: http://fb.com/forbes
Forbes Video on Twitter: http://www.twitter.com/forbes
Forbes Video on Instagram: http://instagram.com/forbes
More From Forbes: http://forbes.com

Forbes covers the intersection of entrepreneurship, wealth, technology, business and lifestyle with a focus on people and success.

Continue Reading
Advertisement
Comments

Video

How To Ace A Virtual Presentation | Forbes

Published

on

By

As conferences and other professional events transition to virtual events for the foreseeable future, many professionals will need to get comfortable in a space where they’re most likely not comfortable right now – virtual presenting. Contrary to popular belief, virtual presenting done well requires conscious adjustments to simulate the benefits of a live presentation. For those who do it well, there are five common mistakes they avoid.

Read the more about virtual presentations on Forbes: https://www.forbes.com/sites/danabrownlee/2020/05/17/presenting-virtually-dont-make-these-5-tragic-virtual-presentation-mistakes/#567ff2b1234d

Subscribe to FORBES: https://www.youtube.com/user/Forbes?sub_confirmation=1

Stay Connected
Forbes newsletters: https://newsletters.editorial.forbes.com
Forbes on Facebook: http://fb.com/forbes
Forbes Video on Twitter: http://www.twitter.com/forbes
Forbes Video on Instagram: http://instagram.com/forbes
More From Forbes: http://forbes.com

Forbes covers the intersection of entrepreneurship, wealth, technology, business and lifestyle with a focus on people and success.

Continue Reading

Video

How Oprah Made Her $2.6 Billion Dollar Fortune | Forbes

Published

on

By

Oprah Winfrey returned to the Forbes list of top-earning celebrities in 2020 landing at No. 91 with estimated earnings of $37 million before taxes and fees, thanks mostly to a lucrative Apple TV+ deal.

Winfrey’s return to the small screen landed her back on the Celebrity 100, which tracks annual earnings for performers, athletes and other front-of-the-camera stars. The nine-figure deal with Apple—the actual number has never been revealed—put her back in the mix as a performer and brought her an estimated $10 million this year, with a much larger payout coming later in the deal. The rest of her earnings are mostly made up of profits from television network OWN—she owns a 25% stake—payments from WW WW (formerly Weight Watchers) and her deal with Hearst to produce O, The Oprah Magazine. Winfrey has a net worth of $2.6 billion.

Read the full profile on Forbes: https://www.forbes.com/sites/maddieberg/2020/06/04/inside-oprahs-return-to-the-celebrity-100/#6b615e9932d8

Subscribe to FORBES: https://www.youtube.com/user/Forbes?sub_confirmation=1

Stay Connected
Forbes newsletters: https://newsletters.editorial.forbes.com
Forbes on Facebook: http://fb.com/forbes
Forbes Video on Twitter: http://www.twitter.com/forbes
Forbes Video on Instagram: http://instagram.com/forbes
More From Forbes: http://forbes.com

Forbes covers the intersection of entrepreneurship, wealth, technology, business and lifestyle with a focus on people and success.

Continue Reading

Video

How Entrepreneur Rhonesha Byng Created A Mantra From Her Name | Unfiltered | Forbes

Published

on

By

This week on Unfiltered, we spoke with Her Agenda Founder and CEO Rhonesha Byng to talk about how she went from high school intern to publication founder, how she used her name to create a motto and how she deals with her fear of failing her community.

Subscribe to FORBES: https://www.youtube.com/user/Forbes?sub_confirmation=1

Stay Connected
Forbes newsletters: https://newsletters.editorial.forbes.com
Forbes on Facebook: http://fb.com/forbes
Forbes Video on Twitter: http://www.twitter.com/forbes
Forbes Video on Instagram: http://instagram.com/forbes
More From Forbes: http://forbes.com

Forbes covers the intersection of entrepreneurship, wealth, technology, business and lifestyle with a focus on people and success.

Continue Reading

Trending